SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    K. Skalsky, D. Yahav, A. Lador, N. Eliakim-Raz, L. Leibovici, M. Paul, Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials, Clinical Microbiology and Infection, 2013, 19, 4
  2. 2
    Jerry M. Zuckerman, Fozia Qamar, Bartholomew R. Bono, Review of Macrolides (Azithromycin, Clarithromycin), Ketolids (Telithromycin) and Glycylcyclines (Tigecycline), Medical Clinics of North America, 2011, 95, 4, 761

    CrossRef

  3. 3
    DAVID C. HOOPER, JACOB STRAHILEVITZ, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 2010,

    CrossRef

  4. 4
    C. M. Jespersen, H. J. Kolmos, N. Frydendall, J. Hilden, C. Gluud, J. F. Hansen, Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial, Journal of Antimicrobial Chemotherapy, 2009, 64, 2, 411

    CrossRef

  5. 5
    Jerry M. Zuckerman, Fozia Qamar, Bartholomew R. Bono, Macrolides, Ketolides, and Glycylcyclines: Azithromycin, Clarithromycin, Telithromycin, Tigecycline, Infectious Disease Clinics of North America, 2009, 23, 4, 997

    CrossRef

  6. 6
    Wael E Shams, Martin E Evans, Guide to Selection of Fluoroquinolones in Patients with Lower Respiratory Tract Infections, Drugs, 2005, 65, 7, 949

    CrossRef

  7. You have free access to this content7
    Lise M Bjerre, Theo JM Verheij, Michael M Kochen, Antibiotics for community acquired pneumonia in adult outpatients, The Cochrane Library,